Qualification Type: | PhD |
---|---|
Location: | Plymouth |
Funding for: | UK Students, International Students |
Funding amount: | The studentship is supported for 3 years and includes full Home tuition fees plus a stipend of £18,655 |
Hours: | Full Time |
Placed On: | 4th June 2024 |
---|---|
Closes: | 30th June 2024 |
DoS: Dr. Eve Kelland (eve.kelland@plymouth.ac.uk)
2nd Supervisor: Dr. Richard Hosking (richard.hosking@plymouth.ac.uk)
3rd Supervisor: Dr. Holly Stephenson (holly.stephenson@plymouth.ac.uk)
4th Supervisor: Dr. David Hilton (davidhilton@nhs.net)
Applications are invited for a three-year PhD studentship. The studentship will start on 1st October 2024 or 1st January 2025.
Project Description
Disability and dementia define the devastating diseases Multiple Sclerosis (MS) and Alzheimer’s Disease (AD), but what drives the neuroinflammation and neurodegeneration? New research is focusing on the choroid plexus (ChP), a highly vascular structure hidden deep in the brain’s fluid-filled cavities. ChP is emerging as a major interface between the peripheral immune and central nervous system, an area of increasing importance in MS and AD. However, ChP also transports thyroid hormone (TH) into cerebrospinal fluid (CSF) which is then distributed throughout the brain.
TH is vital for neurophysiology and immunometabolism such as neurogenesis, growth factors, myelination, synapse formation, microglial activation and phagocytosis. Moreover, work shows ChP is inflamed in MS and AD where it may be vulnerable to pathogens including SARS-CoV-2.
This PhD will help determine if MS and AD ChP pathology leads to altered TH transport that then causes chronic inflammation and neurodegeneration in MS and AD. The student will use cutting-edge facilities to study TH metabolism and develop expertise in a range of laboratory techniques. These involve isolation of blood macrophages and in vitro cell culture for a human ChP model with immune assays and western blot; MS and AD human tissue bank brain and ChP samples for immunohistochemistry and fluorescence microscopy.
Overall, the project explores exciting concepts in macrophage biology, neurobiology, neurology and neuropathology. It is hoped the data will contribute to new clinical imaging and drug trials for MS and AD.
Eligibility
Applicants should have a first or upper second class honours degree in an appropriate biology related subject. A masters qualification or previous laboratory experience within the area of neuroscience would be an advantage.
If your first language is not English, you will need to meet the minimum English requirements for the programme, IELTS Academic score of 6.5 (with no less than 5.5 in each component test area) or equivalent.
The studentship is supported for 3 years and includes full home tuition fees plus a stipend of £18,655 per annum 2024/25 rate. The studentship will only fully fund those applicants who are eligible for home fees with relevant qualifications. Applicants normally required to cover international fees will have to cover the difference between the Home and the international tuition fee rates.
If you wish to discuss this project further informally, please contact Eve Kelland (eve.kelland@plymouth.ac.uk) or Richard Hosking (richard.hosking@plymouth.ac.uk)
To apply for this position please click on the Apply button above.
Please clearly state the name of the studentship project that you are applying for on the top of your personal statement.
Please see here for a list of supporting documents to upload with your application.
For more information on the admissions process generally, please visit our How to Apply for a Research Degree webpage or contact the Doctoral College.
The closing date for applications is 30th June 2024 at 15:00 (London, UK time). Shortlisted candidates will be invited for interview before the end of July 2024.
Type / Role:
Subject Area(s):
Location(s):